209 related articles for article (PubMed ID: 11568738)
1. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis.
Tzaneva S; Seeber A; Schwaiger M; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2001 Oct; 45(4):503-7. PubMed ID: 11568738
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.
Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681
[TBL] [Abstract][Full Text] [Related]
3. 5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial.
Tzaneva S; Kittler H; Holzer G; Reljic D; Weber M; Hönigsmann H; Tanew A
Br J Dermatol; 2010 Mar; 162(3):655-60. PubMed ID: 19769631
[TBL] [Abstract][Full Text] [Related]
4. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study.
Gambichler T; Othlinghaus N; Tomi NS; Holland-Letz T; Boms S; Skrygan M; Altmeyer P; Kreuter A
Br J Dermatol; 2009 Mar; 160(3):652-8. PubMed ID: 19120333
[TBL] [Abstract][Full Text] [Related]
5. Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis.
Majoie IM; Oldhoff JM; van Weelden H; Laaper-Ertmann M; Bousema MT; Sigurdsson V; Knol EF; Bruijnzeel-Koomen CA; de Bruin-Weller MS
J Am Acad Dermatol; 2009 Jan; 60(1):77-84. PubMed ID: 19103360
[TBL] [Abstract][Full Text] [Related]
6. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
[TBL] [Abstract][Full Text] [Related]
7. UVA1 phototherapy for disseminated granuloma annulare.
Schnopp C; Tzaneva S; Mempel M; Schulmeister K; Abeck D; Tanew A
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):68-71. PubMed ID: 15752123
[TBL] [Abstract][Full Text] [Related]
8. Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy.
Breuckmann F; von Kobyletzki G; Avermaete A; Pieck C; Kreuter A; Brockmeyer NH; Altmeyer P; Gambichler T
Eur J Med Res; 2002 Jul; 7(7):315-22. PubMed ID: 12176681
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.
Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T
J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295
[TBL] [Abstract][Full Text] [Related]
10. UVA/UVB phototherapy for atopic dermatitis revisited.
Valkova S; Velkova A
J Dermatolog Treat; 2004 Jul; 15(4):239-44. PubMed ID: 15764039
[TBL] [Abstract][Full Text] [Related]
11. 'High dose' vs. 'medium dose' UVA1 phototherapy in italian patients with severe atopic dermatitis.
Pacifico A; Iacovelli P; Damiani G; Ferraro C; Cazzaniga S; Conic RRZ; Leone G; Morrone A
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):718-724. PubMed ID: 30468530
[TBL] [Abstract][Full Text] [Related]
12. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
[TBL] [Abstract][Full Text] [Related]
13. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States.
Tuchinda C; Kerr HA; Taylor CR; Jacobe H; Bergamo BM; Elmets C; Rivard J; Lim HW
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):247-53. PubMed ID: 16948826
[TBL] [Abstract][Full Text] [Related]
14. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
[TBL] [Abstract][Full Text] [Related]
15. Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: controlled study with half-side comparison analysis.
Durand F; Staumont D; Bonnevalle A; Hachulla E; Hatron PY; Thomas P
Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):215-21. PubMed ID: 17986056
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
17. Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis.
von Kobyletzki G; Pieck C; Hoffmann K; Freitag M; Altmeyer P
J Am Acad Dermatol; 1999 Dec; 41(6):931-7. PubMed ID: 10570376
[TBL] [Abstract][Full Text] [Related]
18. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life.
Czech W; Bräutigam M; Weidinger G; Schöpf E
J Am Acad Dermatol; 2000 Apr; 42(4):653-9. PubMed ID: 10727313
[TBL] [Abstract][Full Text] [Related]
19. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
[TBL] [Abstract][Full Text] [Related]
20. UVA-1 cold light therapy in the treatment of atopic dermatitis: 61 patients treated in the Leiden University Medical Center.
Polderman MC; Wintzen M; le Cessie S; Pavel S
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):93-6. PubMed ID: 15752127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
